Biography
Nahel Yaziji joined King’s College London in 2021 as a research associate. He is a qualified pharmacist and holds an MSc in Public Health. He obtained training on economic evaluation, decision modelling and financial mathematics. He works on the economic evaluation component of various projects.
Prior to joining King’s Health Economics, Nahel was working with the Academic Unit of Health Economics at the University of Leeds. He was involved in a range of research activities that covered systematic reviews, within trial analyses, and decision modelling. Nahel also contributed to the teaching of 'Introduction to Health Economics' and 'Regression Analysis for Quantifying Trends.'
Research interests
- Mental health economics
- Costing methodologies
- Applied health economic
- Economic modelling
Research
King's Health Economics
King's Health Economics, led by Professor Sarah Byford (Director), and Dr Barbara Barrett (Deputy Director), consists of a team of health economists with expertise in designing and conducting high quality economic evaluations of healthcare programmes and policies that contribute to healthcare policy and practice in the UK and abroad.
Lithium versus Quetiapine in Depression (LQD) study
Researchers at King's College London ran the LQD study to find the effectiveness of lithium and quetiapine in the treatment of difficult-to-treat depression.
Project status: Completed
Research
King's Health Economics
King's Health Economics, led by Professor Sarah Byford (Director), and Dr Barbara Barrett (Deputy Director), consists of a team of health economists with expertise in designing and conducting high quality economic evaluations of healthcare programmes and policies that contribute to healthcare policy and practice in the UK and abroad.
Lithium versus Quetiapine in Depression (LQD) study
Researchers at King's College London ran the LQD study to find the effectiveness of lithium and quetiapine in the treatment of difficult-to-treat depression.
Project status: Completed